Pathophysiology of critical illness hyperglycemia in children

Insights

Critical illness hyperglycemia in children is often caused by beta-cell dysfunction, not just insulin resistance. This finding in pediatric critical care highlights key differences from adult patient populations.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Metabolic Disorders

Background:

  • Hyperglycemia in critically ill children (CIH) may have different causes than in adults.
  • Understanding CIH pathogenesis is crucial for effective patient management.
  • Key factors include insulin resistance and beta-cell dysfunction.

Purpose of the Study:

  • To investigate the pathogenesis of CIH in non-diabetic children.
  • To differentiate the roles of insulin resistance and beta-cell dysfunction in pediatric CIH.
  • To analyze glucose regulation during hyperglycemic and euglycemic states.

Main Methods:

  • Enrolled critically ill children with blood glucose >150 mg/dL.
  • Assessed insulin sensitivity and beta-cell function using BG/insulin and BG/C-peptide ratios.
  • Utilized Homeostasis Model Assessment (HOMA) for HOMA-B and HOMA-S scores.

Main Results:

  • BG/insulin and BG/C-peptide ratios were significantly higher during hyperglycemia.
  • In survivors, 20 patients exhibited beta-cell dysfunction, and 11 showed insulin resistance.
  • Beta-cell dysfunction was significantly more prevalent during the hyperglycemic period (p<0.001).

Conclusions:

  • Beta-cell dysfunction is a primary contributor to the pathophysiology of CIH in children.
  • Pediatric CIH pathogenesis shares similarities with adult conditions, emphasizing beta-cell dysfunction.
  • Further research can refine treatment strategies for hyperglycemia in critically ill children.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...